OSE Immunotherapeutics Reports Full Year 2023 Financial Results and Provides Business Strategy Update
GlobeNewswire
--------------------**Financial highlights**
· *€18.7 million available cash as of December 31^st, 2023, not..
--------------------**Financial highlights**
· *€18.7 million available cash as of December 31^st, 2023, not..
NEW YORK, March 12, 2024 (GLOBE NEWSWIRE) -- ODDITY Tech Ltd. (“ODDITY”) today announced the commencement of an underwritten..
*The Company has reported new contracts, renewals or orders valued at approximately $2.8 million CAD so far in 2024, outpacing..